[1]陈依然侯钰坤朱昱杨博涵吴问汉谢学海**.机器人辅助手术应用于保留器官功能胰腺切除术的安全性评价[J].中国微创外科杂志,2026,01(3):0.
　Chen Yiran,Hou Yukun,Zhu Yu,et al.Safety Evaluation of Robotassisted Surgery for Organpreserving Pancreatectomy[J].Chinese Journal of Minimally Invasive Surgery,2026,01(3):0.
点击复制

机器人辅助手术应用于保留器官功能胰腺切除术的安全性评价()

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2026年3期
页码:
0
栏目:
临床研究
出版日期:
2026-03-26

文章信息/Info

Title:
Safety Evaluation of Robotassisted Surgery for Organpreserving Pancreatectomy
作者:
陈依然侯钰坤朱昱杨博涵吴问汉谢学海**
(北京大学第一医院肝胆胰外科，北京100034)
Author(s):
Chen Yiran;  Hou Yukun;  Zhu Yu;  et al.
Department of Hepatobiliary & Pancreatic Surgery, Peking University First Hospital, Beijing 100034, China
关键词:
机器人辅助手术; 保留器官功能胰腺切除术
Keywords:
Robotassisted surgery; Organpreserving pancreatectomy
文献标志码:
A
摘要:
目的评价机器人辅助手术(robotassisted surgery，RAS)应用于保留器官功能胰腺切除术(organpreserving pancreatectomy，OPP)的围手术期安全性。方法回顾性分析2023年1月~2025年5月我院32例接受机器人辅助OPP的临床资料，其中保留脾脏的胰体尾切除术(spleenpreserving distal pancreatectomy，SPDP)18例，肿瘤剜除术(tumor enucleation，EN)13例，保留十二指肠的胰头切除术(duodenumpreserving pancreatic head resection，DPPHR)1例。观察围手术期指标(手术时间、术中出血、术后住院时间)和并发症(术后胰漏、术后胆漏、术后出血、腹腔感染、胃排空延迟)发生情况。结果32例无中转腹腔镜、中转开腹，无围手术期二次手术及死亡病例。SPDP组中位手术时间196.0(155.8，257.0)min，中位术中出血量50.0(42.5，200.0)ml，中位术后住院时间8.0(6.5，11.3)d；术后B/C级胰漏发生率27.8%(5/18)，术后出血发生率5.6%(1/18)，围手术期ClavienDindo Ⅲ~Ⅳ级并发症发生率27.8%(5/18)。EN组中位手术时间187.0(115.5，282.5)min，中位术中出血量20.0(12.5，50.0)ml，中位术后住院时间9.0(6.5，15.0)d；术后B/C级胰漏发生率46.2%(6/13)，术后出血发生率77%(1/13)，胃排空延迟发生率7.7%(1/13)，围手术期ClavienDindo Ⅲ~Ⅳ级并发症发生率46.2%(6/13)。DPPHR手术时间207 min，术中出血量25 ml，术后住院时间19 d；术后发生B/C级胰漏和胃排空延迟(ClavienDindo Ⅲ~Ⅳ级)。32例中位随访时间10(7，19)个月，所有患者均未出现二次入院、肿瘤复发、转移及死亡。结论RAS用于OPP围手术期安全性良好。
Abstract:
ObjectiveTo evaluate the perioperative safety of robotassisted surgery (RAS) for organpreserving pancreatectomy (OPP).MethodsA retrospective descriptive analysis was performed on 32 patients who underwent robotassisted OPP in this hospital between January 2023 and May 2025, including 18 cases of spleenpreserving distal pancreatectomy (SPDP), 13 cases of tumor enucleation (EN), and 1 case of duodenumpreserving pancreatic head resection (DPPHR). Perioperative indicators, including operative time, intraoperative blood loss, and postoperative hospital stay, as well as complications such as pancreatic fistula, biliary fistula, hemorrhage, abdominal infection, and delayed gastric emptying, were analyzed.ResultsAmong the 32 patients, no conversion to laparoscopy or open surgery was required, and no reoperation or mortality during the perioperative period occurred. In the SPDP group, the median operative time was 196.0 min (IQR, 155.8-257.0 min), the median intraoperative blood loss was 50.0 ml (IQR, 42.5-200.0 ml), and the median postoperative length of stay was 8.0 d (IQR, 6.5-11.3 d). The incidence of grade B/C pancreatic fistula was 27.8% (5/18). The postoperative hemorrhage occurred in 5.6% (1/18) of the patients. The perioperative ClavienDindo grade ⅢⅣ complication rate was 27.8% (5/18). In the EN group, the median operative time was 187.0 min (IQR, 115.5-282.5 min), the median blood loss was 20.0 ml (IQR, 12.5-50.0 ml), and the median postoperative length of stay was 9.0 d (IQR, 6.5-15.0 d). The incidence of grade B/C pancreatic fistula was 46.2% (6/13). The postoperative hemorrhage occurred in 7.7% (1/13) and delayed gastric emptying in 7.7% (1/13) of the patients. The perioperative ClavienDindo grade ⅢⅣ complication rate was 46.2% (6/13). The operative time for DPPHR was 207 min with an intraoperative blood loss of 25 ml. The postoperative length of stay was 19 d. The patient developed grade B/C pancreatic fistula and delayed gastric emptying (ClavienDindo grade ⅢⅣ complications). The median followup time for the 32 patients was 10 months (IQR, 7-19 months). No patient required readmission, and no tumor recurrence, metastasis, or death was observed. ConclusionRAS for OPP demonstrates favorable perioperative safety.

参考文献/References:

[1]Singhi AD,Koay EJ,Chari ST,et al.Early detection of pancreatic cancer:opportunities and challenges.Gastroenterology,2019,156(7):2024-2040.
[2]中华医学会外科学分会胰腺外科学组.胰腺囊性疾病诊治指南(2015版).中华消化外科杂志,2015,14(9):689-693.
[3]Beger HG,Mayer B,Poch B.Duodenumpreserving pancreatic head resection for benign and premalignant tumorsa systematic review and metaanalysis of surgeryassociated morbidity.J Gastrointest Surg,2023,27(11):2611-2627.
[4]陈依然,田孝东,杨尹默.再谈保留十二指肠的胰头切除术.中华外科杂志,2024,62(10):913-917.
[5]Beger HG,Mayer B,杨尹默,等.保留十二指肠的胰头切除术治疗良性肿瘤、囊性肿瘤及神经内分泌瘤的系统分析.中华外科杂志,2021,59(7):608-617.
[6]Zhen TT,Li SZ,Pan ST,et al.Nonalcoholic fatty liver disease following laparoscopic duodenumpreserving pancreatic total head resection vs laparoscopic pancreaticoduodenectomy:a retrospective cohort study.World J Gastroenterol,2025,31(13):104046.
[7]Ikenaga N,Nakata K,Abe T,et al.Clinical efficacy of pancreaspreserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma.Surgery，2025,178:108958.
[8]徐盟,秦仁义.腹腔镜胰腺手术器官保留的技巧和运用.临床外科杂志,2021,29(7):604-606.
[9]中国研究型医院学会微创外科专业委员会,中国研究型医院学会智能医学专业委员会.胰管(修复)外科专家共识.中华腔镜外科杂志(电子版),2025,18(2):65-72.
[10]中华医学会外科学分会胰腺外科学组,中国研究型医院学会胰腺疾病专业委员会,中华外科杂志编辑部.胰腺术后外科常见并发症防治指南(2022).中华外科杂志,2023,61(7):529-534.
[11]Beger HG,Nakao A,Mayer B,et al.Duodenumpreserving total and partial pancreatic head resection for benign tumors:systematic review and metaanalysis.Pancreatology,2015,15(2):167-178.
[12]Beger HG,Büchler M,Bittner RR,et al.Duodenumpreserving resection of the head of the pancreas in severe chronic pancreatitis.Early and late results.Ann Surg,1989,209(3):273-278.
[13]Frey CF,Smith GJ.Description and rationale of a new operation for chronic pancreatitis.Pancreas,1987,2(6):701-707.
[14]Takada T,Yasuda H,Uchiyama K,et al.Duodenumpreserving pancreatoduodenostomy.A new technique for complete excision of the head of the pancreas with preservation of biliary and alimentary integrity.HepatoGastroenterology,1993,40(4):356-359.
[15]吴文铭,陈洁,白春梅,等.中国胰腺神经内分泌肿瘤诊疗指南(2020).中华外科杂志,2021,59(6):401-421.
[16]Zhou S,Chen MY,Lu Z,et al.Robotic distal pancreatectomy using the Warshaw technique demonstrated superior shortterm prognosis compared to the laparoscopic approach:propensitymatched cohort study.Surg Endosc,2025,39(5):3057-3067.
[17]鲁超,金巍巍,牟一平,等.微创保留十二指肠的胰头切除术治疗胰头良性和交界性肿瘤的临床效果分析.中华外科杂志,2022,60(1):39-45.
[18]Song KB,Kim SC,Park KM,et al.Laparoscopic central pancreatectomy for benign or lowgrade malignant lesions in the pancreatic neck and proximal body.Surg Endosc,2015,29(4):937-946.
[19]Li SZ,Zhen TT,Wu Y,et al.Quality of life after pancreatic surgery.World J Gastroenterol,2024,30(8):943-955.
[20]Beger HG,Mayer B,Vasilescu C,et al.Longterm metabolic morbidity and steatohepatosis following standard pancreatic resections and parenchymasparing,local extirpations for benign tumor:a systematic review and metaanalysis.Ann Surg,2022,275(1):54-66.
[21]Qin H,Yang S,Yang W,et al.Duodenumpreserving pancreas head resection in the treatment of pediatric benign and lowgrade malignant pancreatic tumors.HPB (Oxford),2020,22(2):306-311.
[22]Wang M,Peng B,Liu J,et al.Practice patterns and perioperative outcomes of laparoscopic pancreaticoduodenectomy in China:a retrospective multicenter analysis of 1029 patients.Ann Surg,2021,273(1):145-153.
[23]刘文生,刘梦奇,虞先濬,等.浅谈微创外科时代机器人保留脏器/功能胰腺手术若干问题.加速康复外科杂志,2021,4(3):97-101.

备注/Memo

备注/Memo:
基金项目：北京大学第一医院院内交叉临床研究专项(2022CR12)**通讯作者，Email：xiexuehai@pkufh.com
更新日期/Last Update: 2026-03-26